Thermo Fisher Agrees To Acquire Affymetrix For $1.3 Billion

Thermo Fisher Scientific Inc. said late Friday it agreed to acquire biological test company Affymetrix Inc. for $14 a share cash, or $1.3 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.